IP Library Granted Patent US 7,504,088
Granted Patent B2
US 7,504,088 · App. 11/146,651 · Granted Mar 17, 2009

Lipophilic derivatives of chelate monoamides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,504,088
App. No.
11/146,651
Granted
Mar 17, 2009
Kind
B2
Abstract

Compounds useful for associating with nanoparticle or microparticle emulsions to obtain magnetic resonance images permit control of the relaxivity of the signal and readily associate with the particulate components. The compounds are conveniently prepared from achiral derivatives of chelating moieties.

Claims (22)

1. A compound of the formula:

wherein Ch′ is a residue of a chelating agent comprising at least four nitrogen atoms and (n−1) carboxyl groups, where n is the number of nitrogen atoms in the chelating moiety;

W is O or S;

X is NR 1 , S or O;

M + is a counter-ion;

each R 1 is H or alkyl (C 1-4 );

each R 2 COO is a residue of a naturally occurring fatty acid or a mixture of said residues;

spacer 1 is a C 1-10 alkyl;

spacer 2 is a C 1-10 alkyl, or

wherein n is 1-6 and m is 1-6;

and wherein said compound is negatively charged when dissolved in water under physiological conditions.

2. The compound of claim 1 , wherein spacer 2 is CH 2 CH 2 .

3. The compound of claim 1 , wherein spacer 1 is ethylene, tetramethylene, or hexamethylene.

4. The compound of claim 3 , wherein said spacer 1 is hexamethylene.

5. The compound of claim 1 , wherein Ch′ is a residue of 1,4,7,10-tetra-azacyclododecane-N,N′,N″,N′″-tetraacetic acid (DOTA) having one less carboxyl group than DOTA.

6. The compound of claim 1 , wherein each R 1 is H.

7. The compound of claim 1 , which further comprising a paramagnetic metal chelated to Ch′.

8. The compound of claim 7 , wherein said paramagnetic metal ion is nonradioactive.

9. The compound of claim 1 , wherein said compound has the following formula

wherein M + is a counter-ion.

10. The compound of claim 7 , wherein the paramagnetic metal ion is Gd(3+).

11. The compound of claim 10 , wherein Ch′ is a residue of DOTA having one less carboxyl group than DOTA.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded May 3, 2010
From: PROLOG CAPITAL II, L.P.; CHARTER LIFE SCIENCES, L.P.; MEMPHIS BIOMED VENTURES II, L.P.; TRIATHLON MEDICAL VENTURES FUND, L.P.; ADVANTAGE CAPITAL COMMUNITY DEVELOPMENT FUND XV, LLC; ALAFI CAPITAL COMPANY, LLC; APJOHN VENTURES FUND, LP; VECTIS LIFE SCIENCES FUND I, L.P.; WICKLINE, SAMUEL A., M.D.; 1998 CO-INVESTING LLC; C. AGANOSTOPOULOS REVOCABLE TRUST U/A 12/21/1978
To: KEREOS, INC.
Reel/Frame 024320/0741 →
SECURITY AGREEMENT Recorded Jul 17, 2009
From: KEREOS, INC.
To: PROLOG CAPITAL II, L.P.; CHARTER LIFE SCIENCES, L.P.; MEMPHIS BIOMED VENTURES II, L.P.; TRIATHLON MEDICAL VENTURES FUND L.P.; ADVANTAGE CAPITAL COMMUNITY DEVELOPMENT FUND XV, LLC; ALAFI CAPITAL COMPANY, LLC; APJOHN VENTURES FUND, LP; VECTIS LIFE SCIENCES FUND I, L.P.; WICKLINE, SAMUEL A., M.D.; 1998 CO-INVESTING LLC; C. AGANOSTOPOULOS REVOCABLE TRUST U/A 12/21/1978
Reel/Frame 022960/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2005
From: RILEY, DENNIS PATRICK; MCGHEE, WILLIAM D.
To: KEREOS, INC.
Reel/Frame 016846/0063 →